HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$8.50
Day range
$8.25 - $8.88
Year range
$5.15 - $16.81
Market cap
740.82M USD
Avg Volume
1.36M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.74M | -28.44% |
Operating expense | 10.45M | 29.93% |
Net income | -80.25M | 13.37% |
Net profit margin | -2.93K | -21.05% |
Earnings per share | -1.11 | -638.03% |
EBITDA | -55.15M | -302.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.30M | 57.30% |
Total assets | 240.24M | 61.73% |
Total liabilities | 59.08M | 106.14% |
Total equity | 181.16M | — |
Shares outstanding | 86.95M | — |
Price to book | 3.02 | — |
Return on assets | -55.92% | — |
Return on capital | -68.87% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -80.25M | 13.37% |
Cash from operations | -42.06M | -140.91% |
Cash from investing | 9.76M | 132.52% |
Cash from financing | 20.08M | -63.81% |
Net change in cash | -12.22M | -251.99% |
Free cash flow | -15.21M | -16.85% |
About
Founded
2006
Headquarters
Website
Employees
118
